Clearstead Trust LLC Acquires 565 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Clearstead Trust LLC increased its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 5.1% in the fourth quarter, according to its most recent disclosure with the SEC. The firm owned 11,623 shares of the healthcare conglomerate’s stock after purchasing an additional 565 shares during the period. UnitedHealth Group accounts for approximately 1.3% of Clearstead Trust LLC’s holdings, making the stock its 15th largest position. Clearstead Trust LLC’s holdings in UnitedHealth Group were worth $5,879,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also bought and sold shares of the company. NewSquare Capital LLC bought a new position in UnitedHealth Group during the fourth quarter worth about $25,000. AlphaMark Advisors LLC bought a new stake in shares of UnitedHealth Group during the fourth quarter worth approximately $30,000. Promus Capital LLC bought a new stake in shares of UnitedHealth Group during the fourth quarter worth approximately $32,000. RPg Family Wealth Advisory LLC bought a new stake in shares of UnitedHealth Group during the third quarter worth approximately $37,000. Finally, Pillar Financial Advisors LLC bought a new stake in shares of UnitedHealth Group during the fourth quarter worth approximately $40,000. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Up 1.5 %

Shares of NYSE:UNH opened at $488.52 on Friday. The firm has a market cap of $446.85 billion, a P/E ratio of 31.52, a P/E/G ratio of 1.37 and a beta of 0.62. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $630.73. The business has a fifty day simple moving average of $511.36 and a 200 day simple moving average of $550.33.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.74 by $0.07. The business had revenue of $100.81 billion during the quarter, compared to analyst estimates of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. UnitedHealth Group’s revenue for the quarter was up 6.8% compared to the same quarter last year. During the same period last year, the company earned $5.83 EPS. Analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th will be issued a dividend of $2.10 per share. The ex-dividend date of this dividend is Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a yield of 1.72%. UnitedHealth Group’s payout ratio is currently 54.19%.

Analyst Upgrades and Downgrades

Several equities research analysts recently issued reports on the company. Hsbc Global Res upgraded UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research note on Friday, January 10th. Piper Sandler cut their price target on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating for the company in a research note on Thursday, January 2nd. Wells Fargo & Company cut their price target on UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating for the company in a research note on Tuesday, January 28th. Oppenheimer boosted their price target on UnitedHealth Group from $610.00 to $640.00 and gave the company an “outperform” rating in a research note on Friday, December 6th. Finally, Barclays lowered their price objective on shares of UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating for the company in a research report on Friday, January 17th. Twenty analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, UnitedHealth Group presently has a consensus rating of “Buy” and an average target price of $629.32.

Insiders Place Their Bets

In other UnitedHealth Group news, Director Timothy Patrick Flynn purchased 1,000 shares of the firm’s stock in a transaction on Friday, January 17th. The stock was purchased at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the acquisition, the director now owns 4,500 shares in the company, valued at approximately $2,302,065. The trade was a 28.57 % increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 0.33% of the company’s stock.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.